Recurrent Hairy Cell Leukemia: Clinical Trials

2 trials for Recurrent Hairy Cell Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Recurrent Hairy Cell Leukemia: new trials by email Literature Review of Recurrent Hairy Cell Leukemia trials Research Report on Recurrent Hairy Cell Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
Acetaminophen, Dexamethasone, Diphenhydramine - Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia
Phase 1CompletedCity of Hope Medical Center132020-11-182026-01-28
CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma
Lenalidomide, Obinutuzumab, Oral Azacitidine - Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma
Phase 1CompletedJoseph Tuscano82020-10-232025-04-24

Narrower conditions

Leukemia, Hairy Cell (2)  ·  Blastic Plasmacytoid Dendritic Cell Neoplasm (1)  ·  Burkitt Lymphoma (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Mastocytosis, Systemic (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)

Interventions

Acetaminophen (1)  ·  Azacitidine (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Diphenhydramine (1)  ·  Ibuprofen (1)  ·  Lenalidomide (1)  ·  Ranitidine (1)  ·  auricularum (1)  ·  cc-486 (1)  ·  dexamethasone 21-phosphate (1)  ·  dexamethasone acetate (1)  ·  obinutuzumab (1)

Sponsors

City of Hope Medical Center (1)  ·  Joseph Tuscano (1)

Countries

United States (2)

Top investigators

Ibrahim T Aldoss (1)  ·  Joseph M Tuscano (1)

Results publications

PMID 35622074

NIH funding

P30CA033572 (1), P30CA093373 (1)